University of Edinburgh

Activities: Research & Development

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    kyron.bio partners with Servier to advance precision glycosylation in antibody therapeutics The parternship will allow kyron.bio to apply its precision glycoengineering platform to antibody development. Speaking exclusively with Manufacturing Chemist, CEO of...
  2. Naobios and SGS partner to manufacture RSV challenge agent for vaccine trials Naobios and SGS have partnered to produce a cGMP respiratory syncytial virus challenge agent for Controlled Human Infection Model studies, supporting faster development of...
  3. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change As the Central European outsourcing market matures, companies such as Mabion are redefining the CDMO paradigm with integrated biologics expertise and long-term codevelopment...
  5. FDA rejects uniQure Huntington's gene therapy AMT-130, demands randomised trial The US regulator has refused to accept uniQure's Phase I/II data for AMT-130 as sufficient for approval, calling for a placebo-controlled study and accusing the company of...

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

Related Content

Regulatory

Ananda Pharma receives MHRA and HRA approval for Phase II ENDOCAN trial in endometriosis

UK biopharmaceutical company Ananda Pharma has received regulatory and ethics approval to begin a Phase II clinical trial investigating its proprietary cannabidiol (CBD) therapy for the management of endometriosis-associated pain
Manufacturing

Automated microfluidics for gene editing is in the works

Oxford Genetics has announced a partnership to optimise the way laboratories deliver gene editing to cells and interrogate the resultant products
Manufacturing

Global collaboration to optimise development and quality of particulate products

The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, announced it is collaborating with world-leading partners to develop robust standardised models for formulation development of particulate products across all industry sectors, including pharmaceuticals
Ingredients

Scientists set sights on large-scale output of sought-after blue dye

The ability to mass produce a high-value natural blue dye for use in the food, pharmaceutical and other industries is being developed with help from research scientists
Ingredients

University of Edinburgh licence agreement with life sciences giant supports further understanding of disease

Partnership provides researchers access to pioneering fluorescent probe technology to enhance our understanding of disease action
Research & Development

Flagship DNA facility sets sights on advances in science

The first fully automated DNA production facility in the UK is based at the Edinburgh Genome Foundry in Scotland
Research & Development

Scotland to be at forefront of gene-led healthcare in £15m project with Illumina

Scottish Genomes Partnership will include Universities of Edinburgh and Glasgow
Subscribe now